In the shadow of mega-publishers, Zoonoses Journal has quietly built a $6.7M business by owning the most critical intersection in modern medicine: animal-to-human disease transmission. This isn't just academic publishing—it's a strategic play in global health intelligence.

"They're not competing for clicks—they're competing for citations in a $40B academic publishing industry."

The tech stack reveals their modern approach: Tailwind CSS, Vite, and priority hints show they're optimizing for the few users who matter. They're not chasing mass audiences—they're building for the 44% who find them through search and the 37% who come directly. That's a 81% high-intent traffic profile that most B2B SaaS companies would kill for.

• Revenue model: Likely institutional subscriptions and open-access fees (typical for medical journals)
• Traffic profile: 81% high-intent (direct + organic) suggests quality over quantity
• Social presence: Active on Twitter, Facebook, LinkedIn—building authority, not virality
• Tech stack: Modern, lightweight (Vite, Tailwind) for a lean 24-person operation